Company Pharmacyclics, Inc.
Equities
US7169331060
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
May. 06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
Apr. 29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 15-04-30 | |
Betty Chang
CTO | Chief Tech/Sci/R&D Officer | - | 13-07-08 |
Heow Tan
CTO | Chief Tech/Sci/R&D Officer | 65 | 12-04-30 |
Alvina Chu
PRN | Corporate Officer/Principal | - | - |
Danelle James
PRN | Corporate Officer/Principal | - | - |
Thorsten Graef
PRN | Corporate Officer/Principal | - | 13-07-08 |
Dana Lee
PRN | Corporate Officer/Principal | 60 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 77,079,177 | 62,948,561 ( 81.67 %) | 0 | 81.67 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |
- Stock
- Equities
- Stock Pharmacyclics, Inc. - Nasdaq
- Company Pharmacyclics, Inc.